Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study (CEISTDP)

August 15, 2013 updated by: Nova Scotia Health Authority

Objective: To evaluate whether or not cases treated with Intensive Short-term Dynamic Psychotherapy (ISTDP) facilitate healthcare cost reduction, whether any observed reduction is greater than that of a control group and whether any such gains would be maintained in follow up.

Design: A quasi-experimental design was employed in which pre and post healthcare cost and usage data were extracted for all ISTDP treated cases from 1999 to 2008 and compared to parallel measures of a control group of cases referred but never treated.

Study Overview

Detailed Description

Importance: Psychiatric and psychological disorders result in excess health care service use and costs. Brief psychotherapy methods may be effective across a broad range of mental disorders and could therefore result in healthcare cost reduction.

Objective: To evaluate whether or not cases treated with Intensive Short-term Dynamic Psychotherapy (ISTDP) facilitate healthcare cost reduction, whether any observed reduction is greater than that of a control group and whether any such gains would be maintained in follow up.

Design: A quasi-experimental design was employed in which pre and post healthcare cost and usage data were extracted for all ISTDP treated cases from 1999 to 2008 and compared to parallel measures of a control group of cases referred but never treated.

Setting: Treatments were provided at an urban University based psychotherapy service.

Participants: All cases from the province of Nova Scotia treated within the research time frame were included. 890 patients were included with a very broad range of psychiatric disorders including anxiety, mood, somatoform, personality and psychotic disorders. 192 referred but never see cases served as non randomized controls.

Intervention(s): ISTDP is an emotionally focused form of brief psychotherapy which has supportive, cognitive, experiential and primarily psychodynamic elements. In this setting the average length of treatment was 7.3 sessions and cost an estimated $500 dollars per treatment course.

Study Type

Observational

Enrollment (Actual)

1082

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3H 2E2
        • Capital Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 90 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All Major DSM IV categories included including mood, anxiety, personality, somatoform, dissociative, eating and psychotic disorders

Description

Inclusion Criteria:

  • All patients referred for ISTDP treatment

Exclusion Criteria:

  • Patients not referred for ISTDP treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
ISTDP
Patients provided Intensive Short term Dynamic Psychotherapy
An emotion focused brief psychotherapy format.
Other Names:
  • Intensive Short-term Dynamic Psychotherapy
Control Group
Patients referred for ISTDP but never seen for any reason

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Doctor and Hospital Costs
Time Frame: 1 year pre versus 3 years post
Total Physician and Hospital billings per patient
1 year pre versus 3 years post

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hospital costs
Time Frame: 1 year pre versus 3 years post
Total Hospital costs per patient
1 year pre versus 3 years post
Hospital Days
Time Frame: 1 year per versus 3 years post
Hospital days per patient
1 year per versus 3 years post
Doctor Visits
Time Frame: 1 year pre versus 3 years post
Doctor Costs per patient
1 year pre versus 3 years post
Doctor Costs
Time Frame: 1 year pre versus 3 years post
Doctor costs per patient
1 year pre versus 3 years post

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Allan A Abbass, MD, FRCPC, Nova Scotia Health Authority

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2008

Primary Completion (ACTUAL)

March 1, 2009

Study Completion (ACTUAL)

March 1, 2009

Study Registration Dates

First Submitted

July 25, 2013

First Submitted That Met QC Criteria

August 15, 2013

First Posted (ESTIMATE)

August 16, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

August 16, 2013

Last Update Submitted That Met QC Criteria

August 15, 2013

Last Verified

July 1, 2013

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Personality Disorders

3
Subscribe